{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ATP-binding cassette subfamily B member 1", "caveolin-1", "cell cycle", "multidrug resistance in tumor", "oleanolic acid"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34055052", "DateRevised": {"Year": "2021", "Month": "06", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "05", "Day": "09"}], "Language": ["eng"], "ELocationID": ["735", "10.3892/etm.2021.10167"], "Journal": {"ISSN": "1792-0981", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Experimental and therapeutic medicine", "ISOAbbreviation": "Exp Ther Med"}, "ArticleTitle": "Decrease of ABCB1 protein expression and increase of G<sub>1</sub> phase arrest induced by oleanolic acid in human multidrug-resistant cancer cells.", "Pagination": {"StartPage": "735", "MedlinePgn": "735"}, "Abstract": {"AbstractText": ["Oleanolic acid (OA) is a natural compound that can be found in a number of edible and medicinal plants and confers diverse biological actions. However, the direct target of OA in human tumor cells remains poorly understood, preventing its application in clinical and health settings. A previous study revealed that overexpression of caveolin-1 in human leukemia HL-60 cells can increase its sensitivity to OA. The present study aimed to investigate the effects of OA on the doxorubicin-resistant human breast cancer MCF-7 cell line (MCF-7/DOX), harringtonine-resistant human leukemia HL-60 cells (HL-60/HAR) and their corresponding parental cell lines. Western blotting was performed to measure protein expression levels, whilst Cell Counting Kit-8 (CCK-8) assays, cell cycle analysis (by flow cytometry) and apoptosis assays (with Annexin V/PI staining) were used to assess drug sensitivity. CCK-8 assay results suggested that MCF-7/DOX cells, which overexpress the caveolin-1 protein, have similar OA susceptibility to their parent line. In addition, sensitivity of MCF-7/DOX cells to OA was not augmented by knocking down caveolin-1 using RNA interference. HL-60/HAR cells exhibited a four-fold increased sensitivity to OA compared with that in their parental HL-60 cells according to CCK-8 assay. Both of the resistant cell lines exhibited higher numbers of cells at G<sub>1</sub> phase arrest compared with those in their parent lines, as measured via flow cytometry. Treatment of both MCF-7 cell lines with 100 \u00b5M OA for 48 h induced apoptosis, with increased effects observed in resistant cells. However, no PARP-1 or caspase-3 cleavage was observed, with some positive Annexin V staining found after HL-60/HAR cells were treated with OA, suggesting that cell death occurred via non-classical apoptosis or through other cell death pathways. It was found that OA was not a substrate of ATP-binding cassette subfamily B member 1 (ABCB1) in drug-resistant cells, as indicated by the accumulation of rhodamine 123 assessed using flow cytometry. However, protein expression of ABCB1 in both of the resistant cell lines was significantly decreased after treatment with OA in a concentration-dependent manner. Collectively, these results suggest that OA could reduce ABCB1 protein expression and induce G<sub>1</sub> phase arrest in multidrug-resistant cancer cells. These findings highlight the potential of OA for cancer therapy."], "CopyrightInformation": "Copyright: \u00a9 Wang et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}], "LastName": "Wang", "ForeName": "Didi", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P.R. China."}], "LastName": "Wang", "ForeName": "Jincai", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P.R. China."}], "LastName": "Zhang", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Clinical Medicine, Heilongjiang Nursing College, Harbin, Heilongjiang 150086, P.R. China."}], "LastName": "Yi", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}], "LastName": "Piao", "ForeName": "Jinhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}], "LastName": "Li", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}], "LastName": "Wang", "ForeName": "Jianjie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Microecology-immune Regulatory Network and Related Diseases, School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154000, P.R. China."}], "LastName": "Zhang", "ForeName": "Pengxia", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medicinal Biotechnology, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, P.R. China."}], "LastName": "He", "ForeName": "Qiyang", "Initials": "Q"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Exp Ther Med", "NlmUniqueID": "101531947", "ISSNLinking": "1792-0981"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "\u017diberna L, \u0160amec D, Mocan A, Nabavi SF, Bishayee A, Farooqi AA, Sureda A, Nabavi SM. Oleanolic acid alters multiple cell signaling pathways: Implication in cancer prevention and therapy. Int J Mol Sci. 2017;18(643) doi: 10.3390/ijms18030643.", "ArticleIdList": ["10.3390/ijms18030643", "PMC5372655", "28300756"]}, {"Citation": "Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic acid and its derivatives: Biological activities and therapeutic potential in chronic diseases. Molecules. 2017;22(1915) doi: 10.3390/molecules22111915.", "ArticleIdList": ["10.3390/molecules22111915", "PMC6150249", "29137205"]}, {"Citation": "Liu J, Zheng L, Wu N, Ma L, Zhong J, Liu G, Lin X. Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway. J Agric Food Chem. 2014;62:5528\u20135537. doi: 10.1021/jf500622p.", "ArticleIdList": ["10.1021/jf500622p", "24856665"]}, {"Citation": "Fontana G, Bruno M, Notarbartolo M, Labbozzetta M, Poma P, Spinella A, Rosselli S. Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-\u03baB involvement. Bioorg Chem. 2019;90(103054) doi: 10.1016/j.bioorg.2019.103054.", "ArticleIdList": ["10.1016/j.bioorg.2019.103054", "31212180"]}, {"Citation": "Liu J, Zheng L, Zhong J, Wu N, Liu G, Lin X. Oleanolic acid induces protective autophagy in cancer cells through the JNK and mTOR pathways. Oncol Rep. 2014;32:567\u2013572. doi: 10.3892/or.2014.3239.", "ArticleIdList": ["10.3892/or.2014.3239", "24912497"]}, {"Citation": "Shi Y, Song Q, Hu D, Zhuang X, Yu S, Teng D. Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway. Korean J Physiol Pharmacol. 2016;20:237\u2013243. doi: 10.4196/kjpp.2016.20.3.237.", "ArticleIdList": ["10.4196/kjpp.2016.20.3.237", "PMC4860365", "27162477"]}, {"Citation": "Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial dependent apoptosis. Carcinogenesis. 2013;34:1323\u20131330. doi: 10.1093/carcin/bgt058.", "ArticleIdList": ["10.1093/carcin/bgt058", "23404993"]}, {"Citation": "Mu DW, Guo HQ, Zhou GB, Li JY, Su B. Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling. Int J Clin Exp Pathol. 2015;8:13864\u201313870.", "ArticleIdList": ["PMC4713485", "26823699"]}, {"Citation": "Xu Y, Shu B, Tian Y, Wang G, Wang Y, Wang J, Dong Y. Oleanolic acid induces osteosarcoma cell apoptosis by inhibition of Notch signaling. Mol Carcinog. 2018;57:896\u2013902. doi: 10.1002/mc.22810.", "ArticleIdList": ["10.1002/mc.22810", "29566282"]}, {"Citation": "Poto\u010dnjak I, \u0160imi\u0107 L, Vukeli\u0107 I, Domitrovi\u0107 R. Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity. Food Chem Toxicol. 2019;132(110676) doi: 10.1016/j.fct.2019.110676.", "ArticleIdList": ["10.1016/j.fct.2019.110676", "31306688"]}, {"Citation": "Li HF, Wang XA, Xiang SS, Hu YP, Jiang L, Shu YJ, Li ML, Wu XS, Zhang F, Ye YY, et al. Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells. Drug Des Devel Ther. 2015;9:3017\u20133030. doi: 10.2147/DDDT.S84448.", "ArticleIdList": ["10.2147/DDDT.S84448", "PMC4472077", "26109845"]}, {"Citation": "Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18:452\u2013464. doi: 10.1038/s41568-018-0005-8.", "ArticleIdList": ["10.1038/s41568-018-0005-8", "PMC6622180", "29643473"]}, {"Citation": "Dastvan R, Mishra S, Peskova YB, Nakamoto RK, Mchaourab HS. Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors. Science. 2019;364:689\u2013692. doi: 10.1126/science.aav9406.", "ArticleIdList": ["10.1126/science.aav9406", "PMC6890515", "31097669"]}, {"Citation": "Alam A, Kowal J, Broude E, Roninson I, Locher KP. Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. Science. 2019;363:753\u2013756. doi: 10.1126/science.aav7102.", "ArticleIdList": ["10.1126/science.aav7102", "PMC6800160", "30765569"]}, {"Citation": "Villar VH, V\u00f6gler O, Barcel\u00f3 F, G\u00f3mez-Florit M, Mart\u00ednez-Serra J, Obrador-Hevia A, Mart\u00edn-Broto J, Ruiz-Guti\u00e9rrez V, Alemany R. Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein. J Nutr Biochem. 2014;25:429\u2013438. doi: 10.1016/j.jnutbio.2013.12.003.", "ArticleIdList": ["10.1016/j.jnutbio.2013.12.003", "24491315"]}, {"Citation": "Paszel A, Rubi\u015b B, Bednarczyk-Cwynar B, Zaprutko L, Kaczmarek M, Hofmann J, Rybczy\u0144ska M. Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1. Pharmacol Rep. 2011;63:1500\u20131517. doi: 10.1016/s1734-1140(11)70714-9.", "ArticleIdList": ["10.1016/s1734-1140(11)70714-9", "22358098"]}, {"Citation": "Ma W, Wang DD, Li L, Feng YK, Gu HM, Zhu GM, Piao JH, Yang Y, Gao X, Zhang PX. Caveolin-1 plays a key role in the oleanolic acid-induced apoptosis of HL-60 cells. Oncol Rep. 2014;32:293\u2013301. doi: 10.3892/or.2014.3177.", "ArticleIdList": ["10.3892/or.2014.3177", "24842472"]}, {"Citation": "Chen J, Chen Y, He Q. Action of bleomycin is affected by bleomycin hydrolase but not by caveolin-1. Int J Oncol. 2012;41:2245\u20132252. doi: 10.3892/ijo.2012.1668.", "ArticleIdList": ["10.3892/ijo.2012.1668", "23076812"]}, {"Citation": "He Q, Zhou W, Ji L, Zhang H, He N, Xue S. Characteristics of harringtonine-resistant human leukemia HL60 cell. Zhongguo Yao Li Xue Bao. 1996;17:463\u2013467.", "ArticleIdList": ["9863176"]}, {"Citation": "Zhang J, Chen Y, He Q. Distinct characteristics of Dasatinib-induced pyroptosis in gasdermin E-expressing human lung cancer A549 cells and neuroblastoma SH-SY5Y cells. Oncol Lett. 2020;20:145\u2013154. doi: 10.3892/ol.2020.11556.", "ArticleIdList": ["10.3892/ol.2020.11556", "PMC7285962", "32565942"]}, {"Citation": "Nasim F, Schmid D, Szak\u00e1cs G, Sohail A, Sitte HH, Chiba P, Stockner T. Active transport of rhodamine 123 by the human multidrug transporter P-glycoprotein involves two independent outer gates. Pharmacol Res Perspect. 2020;8(e00572) doi: 10.1002/prp2.572.", "ArticleIdList": ["10.1002/prp2.572", "PMC7105846", "32232949"]}, {"Citation": "Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res. 1987;47:5141\u20135148.", "ArticleIdList": ["2441861"]}, {"Citation": "Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 1993;53:3976\u20133985.", "ArticleIdList": ["8358726"]}, {"Citation": "Gao L, Wang Y, Xu Z, Li X, Wu J, Liu S, Chu P, Sun Z, Sun B, Lin Y, et al. SZC017, a novel oleanolic acid derivative, induces apoptosis and autophagy in human breast cancer cells. Apoptosis. 2015;20:1636\u20131650. doi: 10.1007/s10495-015-1179-0.", "ArticleIdList": ["10.1007/s10495-015-1179-0", "26407982"]}, {"Citation": "Tasdemir E, Maiuri MC, Tajeddine N, Vitale I, Criollo A, Vicencio JM, Hickman JA, Geneste O, Kroemer G. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle. 2007;6:2263\u20132267. doi: 10.4161/cc.6.18.4681.", "ArticleIdList": ["10.4161/cc.6.18.4681", "17890908"]}, {"Citation": "Braga F, Ayres-Saraiva D, Gattass CR, Capella MA. Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy. Cancer Lett. 2007;248:147\u2013152. doi: 10.1016/j.canlet.2006.06.008.", "ArticleIdList": ["10.1016/j.canlet.2006.06.008", "16889888"]}, {"Citation": "Wang H, Zhong W, Zhao J, Zhang H, Zhang Q, Liang Y, Chen S, Liu H, Zong S, Tian Y, et al. Oleanolic acid inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by promoting iNOS dimerization. Mol Cancer Ther. 2019;18:62\u201374. doi: 10.1158/1535-7163.MCT-18-0448.", "ArticleIdList": ["10.1158/1535-7163.MCT-18-0448", "30297361"]}, {"Citation": "Chintharlapalli S, Papineni S, Konopleva M, Andreef M, Samudio I, Safe S. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. Mol Pharmacol. 2005;68:119\u2013128. doi: 10.1124/mol.105.011437.", "ArticleIdList": ["10.1124/mol.105.011437", "15798084"]}, {"Citation": "Wolf D, Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA. 1985;82:790\u2013794. doi: 10.1073/pnas.82.3.790.", "ArticleIdList": ["10.1073/pnas.82.3.790", "PMC397132", "2858093"]}, {"Citation": "Ju JF, Banerjee D, Lenz HJ, Danenberg KD, Schmittgen TC, Spears CP, Sch\u00f6nthal AH, Manno DJ, Hochhauser D, Bertino JR, et al. Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. Clin Cancer Res. 1998;4:1315\u20131322.", "ArticleIdList": ["9607592"]}, {"Citation": "Oprean C, Ivan A, Bojin F, Cristea M, Soica C, Dr\u0103ghia L, Caunii A, Paunescu V, Tatu C. Selective in vitro anti-melanoma activity of ursolic and oleanolic acids. Toxicol Mech Methods. 2018;28:148\u2013156. doi: 10.1080/15376516.2017.1373881.", "ArticleIdList": ["10.1080/15376516.2017.1373881", "28868958"]}, {"Citation": "Kanarek N, Petrova B, Sabatini DM. Dietary modifications for enhanced cancer therapy. Nature. 2020;579:507\u2013517. doi: 10.1038/s41586-020-2124-0.", "ArticleIdList": ["10.1038/s41586-020-2124-0", "32214253"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "9", "Day": "15"}, {"Year": "2021", "Month": "3", "Day": "15"}, {"Year": "2021", "Month": "5", "Day": "31", "Hour": "6", "Minute": "10"}, {"Year": "2021", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34055052", "PMC8138263", "10.3892/etm.2021.10167", "ETM-0-0-10167"]}}], "PubmedBookArticle": []}